shingles in her ear; This spontaneous case was reported by a physician and describes the occurrence of HERPES ZOSTER OTICUS (shingles in her ear) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (COMIRNATY) for an unknown indication.    No Medical History information was reported.   In May 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient received dose of TOZINAMERAN (COMIRNATY) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER OTICUS (shingles in her ear) (seriousness criteria hospitalization prolonged and medically significant). At the time of the report, HERPES ZOSTER OTICUS (shingles in her ear) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Neurological examination: (Negative) negative stroke work-up..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   The patient received first dose of Moderna during first week of May and then two weeks later ended up being hospitalized.  Extreme infection, jaw was dislocated, left side of her eye is watering a lot, cannot close her eyelid completely, two bumps on her face, and in her mouth were the reported symptoms of Herpes zoster oticus.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No treatment information was provided.  Company comment: This spontaneous case concerns a female patient of an unknown age, with no reported medical history, who experienced the unexpected serious (medically significant and hospitalization) events of Herpes zoster oticus on an unknown date after receiving a dose of mRNA-1273 vaccine. Two weeks post vaccination, patient was hospitalized due to infection, with jaw dislocation, left eye lacrimation, partial closure of the eyelid, ear shingles, and bumps on the face and mouth.  Stroke work- up was reported as negative. Clinical course and treatment details were not reported. On an unknown date, patient received Tozinameran vaccine which remain as a confounder. The outcome of event was unknown. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a female patient of an unknown age, with no reported medical history, who experienced the unexpected serious (medically significant and hospitalization) events of Herpes zoster oticus on an unknown date after receiving a dose of mRNA-1273 vaccine. Two weeks post vaccination, patient was hospitalized due to infection, with jaw dislocation, left eye lacrimation, partial closure of the eyelid, ear shingles, and bumps on the face and mouth.  Stroke work- up was reported as negative. Clinical course and treatment details were not reported. On an unknown date, patient received Tozinameran vaccine which remain as a confounder. The outcome of event was unknown. The benefit-risk relationship of mRNA-1273 is not affected by this report.